
Sign up to save your podcasts
Or


The upcoming EUDAMED deadline on May 28, 2026, marks a major shift in how regulatory data is managed under the EU MDR and IVDR.
While many companies believe this transition is simply about uploading documents into a European database, the reality is far more complex.
EUDAMED is not just a database — it is becoming the central regulatory infrastructure of the European medical device ecosystem, connecting manufacturers, notified bodies, regulators, and economic operators.
Why EUDAMED Matters
EUDAMED aims to increase:
• Transparency
• Traceability
• Post-market surveillance
• Regulatory oversight
To achieve this, companies must ensure that their internal data is structured, accurate, and aligned with regulatory expectations.
The Biggest Mistake
The most common misconception is treating EUDAMED as an IT project.
In reality, it is a data governance challenge.
Before uploading any device, companies must clearly define:
• Device families
• Basic UDI-DI and UDI-DI
• Certificate linkage
• Legal manufacturer responsibilities
Many organizations struggle with these fundamentals.
The 7-Step Readiness Checklist
To prepare effectively, QA/RA teams should focus on:
Actor registration (SRN)
Cleaning the device portfolio
Validating the UDI structure
Checking certificate data
Defining legacy device strategy
Assigning data ownership
Performing a dry run
Risks of Delayed Preparation
Companies that delay preparation may face:
• Incomplete or inconsistent data
• Registration delays
• Regulatory bottlenecks
• Internal confusion
EUDAMED could quickly become a regulatory traffic jam for unprepared organizations.
A Practical Timeline
To avoid these risks:
• Immediately: Audit all regulatory data
• Next 1–2 months: Validate UDI structure and device hierarchy
• Before the deadline: Perform a full readiness simulation
Final Takeaway
EUDAMED is not just a compliance requirement — it is a transformation of how regulatory information is managed in Europe.
Companies that prepare early will transition smoothly.
Those that wait may face significant delays and operational challenges.
Social Media to follow
Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi
Twitter: https://twitter.com/elazzouzim
Pinterest: https://www.pinterest.com/easymedicaldevice
Instagram: https://www.instagram.com/easymedicaldevice
This podcast is powered by Podcastics, the easiest platform to create and publish your podcast.
By easymedicaldevice4.8
2020 ratings
The upcoming EUDAMED deadline on May 28, 2026, marks a major shift in how regulatory data is managed under the EU MDR and IVDR.
While many companies believe this transition is simply about uploading documents into a European database, the reality is far more complex.
EUDAMED is not just a database — it is becoming the central regulatory infrastructure of the European medical device ecosystem, connecting manufacturers, notified bodies, regulators, and economic operators.
Why EUDAMED Matters
EUDAMED aims to increase:
• Transparency
• Traceability
• Post-market surveillance
• Regulatory oversight
To achieve this, companies must ensure that their internal data is structured, accurate, and aligned with regulatory expectations.
The Biggest Mistake
The most common misconception is treating EUDAMED as an IT project.
In reality, it is a data governance challenge.
Before uploading any device, companies must clearly define:
• Device families
• Basic UDI-DI and UDI-DI
• Certificate linkage
• Legal manufacturer responsibilities
Many organizations struggle with these fundamentals.
The 7-Step Readiness Checklist
To prepare effectively, QA/RA teams should focus on:
Actor registration (SRN)
Cleaning the device portfolio
Validating the UDI structure
Checking certificate data
Defining legacy device strategy
Assigning data ownership
Performing a dry run
Risks of Delayed Preparation
Companies that delay preparation may face:
• Incomplete or inconsistent data
• Registration delays
• Regulatory bottlenecks
• Internal confusion
EUDAMED could quickly become a regulatory traffic jam for unprepared organizations.
A Practical Timeline
To avoid these risks:
• Immediately: Audit all regulatory data
• Next 1–2 months: Validate UDI structure and device hierarchy
• Before the deadline: Perform a full readiness simulation
Final Takeaway
EUDAMED is not just a compliance requirement — it is a transformation of how regulatory information is managed in Europe.
Companies that prepare early will transition smoothly.
Those that wait may face significant delays and operational challenges.
Social Media to follow
Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi
Twitter: https://twitter.com/elazzouzim
Pinterest: https://www.pinterest.com/easymedicaldevice
Instagram: https://www.instagram.com/easymedicaldevice
This podcast is powered by Podcastics, the easiest platform to create and publish your podcast.

7,941 Listeners

1,167 Listeners

1,470 Listeners

229 Listeners

34 Listeners

92 Listeners

748 Listeners

8,887 Listeners

16 Listeners

3,915 Listeners

866 Listeners

168 Listeners

3 Listeners

2,552 Listeners

3 Listeners